Navigation Links
Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
Date:1/25/2011

EAST BRUNSWICK, N.J., Jan. 25, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that its board of directors has named John H. Johnson as Chief Executive Officer, effective January 31, 2011.  Mr. Johnson will also serve as a member of Savient's board of directors.

Mr. Johnson brings significant biotechnology business experience to Savient.  Most recently, he served as a Senior Vice President of Eli Lilly and Company and President of Lilly Oncology Business Unit.  From August 2007 to November 2009, Mr. Johnson was Chief Executive Officer of ImClone Systems, which develops targeted biologic cancer treatments, and served on ImClone's board of directors until the company was acquired by Lilly in November 2008.  

"John is a seasoned and accomplished leader in the biopharmaceutical industry and we are very fortunate to have him join Savient as our CEO," said Stephen O. Jaeger, Chairman of the Board.  "With the depth of his industry experience, we believe John is the right person to help Savient bring KRYSTEXXA™ (pegloticase) to market and realize this novel drug's full potential, both for our shareholders and those adult patients suffering from chronic gout refractory to conventional therapy.  Since securing FDA approval for KRYSTEXXA in September, we have been focused on bringing this exciting new drug to market.  John is ideally suited to move us the rest of the way down the road."

"I am thrilled to be joining Savient at this exciting time," said Mr. Johnson.  "KRYSTEXXA is a product that has potential to make a significant difference in the lives of patients around the world.  I look forward to working with the dedicated and talented Savient employees to bring relief to those adult patients suffering from chronic gout refractory to conventional therapy.  My focus will be
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Announces Search for CEO
2. Savient Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
4. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
5. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
6. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
7. Savient Pharmaceuticals Announces Dismissal of Class Action Lawsuit
8. Savient Pharmaceuticals To Hold First Quarter 2010 Results
9. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
10. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
11. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between dropping ... health was forgotten. But Audicus , a next-generation ... better this new year. Hearing loss is ... aging population, though it is often unaddressed. Forty-eight million ... has a hearing aid, mainly due to price. Hearing ...
(Date:12/19/2014)... SAN DIEGO , Dec. 18, 2014  RESMED INC. ... report its second quarter of fiscal year 2015 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:12/19/2014)... development with the growth pace keeping at 20%-30% in last ... size of China separating membrane products ... 16.3%. It is projected that China ... 20% in the upcoming years and that the figure by ... integrated membrane industrial system has taken shape in ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2ResMed To Announce Second Quarter 2015 Results 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... , , , , , , , , ... PARIS and LAUSANNE, Switzerland , February 4 ... and Debiopharm Group (Debiopharm), a Swiss-based global,biopharmaceutical group of companies ... unmet medical needs, announce the launch by,Ipsen in France ...
... , , ST. LOUIS , Feb. ... that its Board of Directors declared a quarterly dividend of ... to all shareholders of record on February 15, ... and equipment used by dentists, dental hygienists, dental assistants, and ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Young Innovations, Inc. Board of Directors Declares Quarterly Dividend 2
(Date:12/20/2014)... New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, Bernstein ... study which suggests that children treated with the ... hormone linked to breast development and lactation. The ... at 34 children and adolescents who began treatment ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called the ... In the promotion, all buyers worldwide can enjoy a ... special for the women who are looking for inspired, ... collections of 2015 dresses have been unveiled recently. All ... prices. Visit our website now before they are out ...
(Date:12/20/2014)... The Twin Cities DI Day is ... the nation! Over 250 financial professionals come together each ... the industry, get motivated to protect their clients and ... and overcoming the challenges of disability. , On September ... came together to attend The 13th Annual Twin Cities ...
(Date:12/19/2014)... Today, Balfleet.com , a leading ... its formal dress promotion. All the old and new ... off. , Balfleet.com is well-known for its high quality ... dresses, cocktail dresses and more. Its formal dresses are ... and they can create an elegant look when paired ...
(Date:12/19/2014)... Sub Zero Ice Cream is partnering up with ... the 28th from 2pm-6pm at the Expo Center on the ... FL. , Inquiries regarding time slots and signing up, email ... donating process, Sub Zero Ice Cream & Yogurt will be ... , About Sub Zero Ice Cream & Yogurt , ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2
... by Professor Richard Hayes at the London School of ... to test an innovative combination of strategies to prevent ... ART (PopART), will test the impact of a combination ... HIV, offer of medical circumcision to men who test ...
... symposium will provide information to educate physicians, psychiatrists ... the possibility of neurological repercussions to post-infectious syndromes. ... known about the cause and effect relationship between ... this symposium will raise the medical community,s awareness ...
... (HealthDay News) -- The facts about cancer found on ... information on the disease found on the patient-oriented section ... (PDQ), a comprehensive peer-reviewed cancer database, according to a ... University were hard-pressed to find errors on Wikipedia, they ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... will begin earlier this year, so seniors need to ... they want in 2012, U.S. health officials said Thursday. ... the same for the 99.7 percent of Medicare recipients who ...
... A new study suggests that blocking cancer cells, access ... glioblastoma, the most common and deadly form of brain ... be appropriate for tumors with a hyperactive PI3K signaling ... glioblastomas cases. , Researchers at the Ohio State University ...
... rare but often deadly disease that can strike at any ... women and in the past was referred to as a ... with ovarian cancer that can assist in early detection. Experts ... use of preventive methods, understand the risks and recognize potential ...
Cached Medicine News:Health News:Major grant awarded for HIV prevention study in Africa 2Health News:Major grant awarded for HIV prevention study in Africa 3Health News:Wikipedia Accurate on Cancer Facts, But Hard to Read: Study 2Health News:Enrollment Period for Medicare Starts Early This Year 2Health News:Starving cancer cells of cholesterol might offer a new way to treat brain tumors 2Health News:Early detection is key in the fight against ovarian cancer 2Health News:Early detection is key in the fight against ovarian cancer 3
... The ROYAL™ single-use skin stapler places one ... The staples first penetrate the skin and are ... skin staples are available in two sizes: wide ... closure) and regular (having a clip span of ...
... CONCORDE staplers place one staple ... are activated. The staples first ... then formed, thus holding the ... staple sizes, each contained in ...
... PROXIMATE Skin Staplers place single ... are made of lubricant-coated stainless steel; ... Endo-Surgery makes three different skin staplers ... skin stapler has applications for routine ...
... articulating (22° and 45° in both directions) ... resection, transection and anastomosis for open surgery ... two triple-staggered rows of staples and simultaneously ... The instrument is designed for multiple use ...
Medicine Products: